Ad is loading...
JVMCX
Price
$30.26
Change
+$0.29 (+0.97%)
Updated
Nov 22 closing price
NCVLX
Price
$13.27
Change
+$0.15 (+1.14%)
Updated
Nov 22 closing price
Ad is loading...

JVMCX vs NCVLX

Header iconJVMCX vs NCVLX Comparison
Open Charts JVMCX vs NCVLXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$30.26
Change+$0.29 (+0.97%)
VolumeN/A
CapitalizationN/A
Nuance Concentrated Value Institutional
Price$13.27
Change+$0.15 (+1.14%)
VolumeN/A
CapitalizationN/A
JVMCX vs NCVLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMCX vs. NCVLX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Buy and NCVLX is a StrongBuy.

FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 24.2B vs. NCVLX (175M). NCVLX pays higher dividends than JVMCX: NCVLX (1.75) vs JVMCX (0.01). JVMCX was incepted earlier than NCVLX: JVMCX (13 years) vs NCVLX (13 years). NCVLX is a more actively managed with annual turnover of: 67.00 vs. JVMCX (41.00). JVMCX has a lower initial minimum investment than NCVLX: JVMCX (1000) vs NCVLX (10000). JVMCX annual gain was more profitable for investors over the last year : 21.89 vs. NCVLX (17.39). JVMCX return over 5 years is better than : 43.78 vs. NCVLX (-7.54).
JVMCXNCVLXJVMCX / NCVLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years13 years-
Gain YTD16.7447.731217%
Front LoadN/AN/A-
Min. Initial Investment10001000010%
Min. Initial Investment IRAN/AN/A-
Net Assets24.2B175M13,829%
Annual Yield % from dividends0.011.751%
Returns for 1 year21.8917.39126%
Returns for 3 years8.44-14.11-60%
Returns for 5 years43.78-7.54-581%
Returns for 10 years52.241.323,943%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCDA2.260.12
+5.85%
BioCardia Inc.
OR20.110.25
+1.26%
Osisko Gold Royalties Ltd
AVXL9.110.09
+1.00%
Anavex Life Sciences Corp
TRU99.130.54
+0.54%
TransUnion
NBTX3.79-0.04
-1.09%
Nanobiotix SA